BONUM THERAPEUTICS, INC.

Profile

Company Names

BONUM THERAPEUTICS, INC.

Addresses

1150 EASTLAKE AVENUE E, SUITE 1100, SEATTLE, WA 98109

1616 EASTLAKE AVENUE EAST, SUITE 400, SEATTLE, WA 98102

1616 EASTLAKE AVENUE EAST, SEATTLE, WA 98102

Phone Numbers

206-888-8485

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY

Year Incorporated:

2021

State Incorporated:

DELAWARE

Total Amount Raised:

$73,135,704.00

Number of Funding Rounds:

3
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
3
2026-04-03 
$26,907,396.00 
$32,301,381.00 
$5,393,985.00 
Equity 
2
2022-11-15 
$45,041,421.00 
$93,041,420.00 
$47,999,999.00 
Equity 
1
2021-12-08 
$1,186,887.00 
$3,560,661.00 
$2,373,774.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
GAURAV 
 
AGGARWAL 
DIRECTOR
HYPERION THERAPEUTICS INC   |  NEXTWAVE PHARMACEUTICALS INC   |  AUSPEX PHARMACEUTICALS, INC.   |  VIVO OPPORTUNITY FUND, L.P.   |  VIVO OPPORTUNITY CO-INVEST, L.P.   |  VIVO OPPORTUNITY CO-INVEST (W), L.P.   |  UNICYCIVE THERAPEUTICS, INC.   |  VIVO OPPORTUNITY CAYMAN FUND, L.P.   |  VIVO CAPITAL FUND X, L.P.   |  BONUM THERAPEUTICS, INC.
SAMUEL 
 
BJORK 
DIRECTOR
BONUM THERAPEUTICS, INC.   |  EPIBIOLOGICS, INC.   |  ELEMENTAL MACHINES, INC.
SAMUEL 
 
BLACKMAN 
DIRECTOR
ELEMENTAL TECHNOLOGIES INC   |  BONUM THERAPEUTICS, INC.
KARL 
 
HANDELSMAN 
DIRECTOR
NEOS THERAPEUTICS, INC.   |  GOOD THERAPEUTICS, INC.   |  BONUM THERAPEUTICS, INC.   |  CODON INNOVATION FUND I, LP
DIANE 
 
HOLLENBAUGH 
EXECUTIVE OFFICER
GOOD THERAPEUTICS, INC.   |  BONUM THERAPEUTICS, INC.   |  ABACUS BIOSCIENCE INC.
JOHN 
 
MCKEARN 
DIRECTOR
OTONOMY, INC.   |  LUMENA PHARMACEUTICALS, INC.   |  ZS PHARMA, INC.   |  ALLAKOS INC.   |  VASCULOX, INC.   |  TIOMA THERAPEUTICS, INC.   |  ONCORESPONSE INC   |  GOOD THERAPEUTICS, INC.   |  ADARZA BIOSYSTEMS, INC.   |  BONUM THERAPEUTICS, INC.   |  ONCORESPONSE, INC
JOHN 
 
MULLIGAN 
EXECUTIVE OFFICER, DIRECTOR, PROMOTER
GLYCOSTASIS, INC.   |  GOOD THERAPEUTICS, INC.   |  BONUM THERAPEUTICS, INC.
MITCHELL 
 
MUTZ 
DIRECTOR
AMPLYX PHARMACEUTICALS, INC.   |  PURIGEN BIOSYSTEMS, INC.   |  PANDION THERAPEUTICS, INC.   |  GOOD THERAPEUTICS, INC.   |  PANDION THERAPEUTICS HOLDCO LLC   |  BONUM THERAPEUTICS, INC.   |  EPIBIOLOGICS, INC.   |  OMNIOX, INC.
NEELA 
 
PATEL 
EXECUTIVE OFFICER
GOOD THERAPEUTICS, INC.   |  BONUM THERAPEUTICS, INC.
MONIQUE 
 
SCHIERSING 
DIRECTOR
GOOD THERAPEUTICS, INC.   |  BONUM THERAPEUTICS, INC.
NICHOLAS 
 
WALROD 
DIRECTOR
VENDSCREEN, INC.   |  FISH PEOPLE CORP   |  SECURUS MEDICAL GROUP, INC.   |  FISH PLUS PEOPLE CORP   |  ZERO MASS WATER, INC.   |  3X5 RIVERVEST FUND II, L.P.   |  FISHPEOPLE SEAFOOD, INC.   |  SMART WIRES INC.   |  GOOD THERAPEUTICS, INC.   |  3X5 PARTNERS FUND III, L.P.   |  FERVO ENERGY CO   |  BONUM THERAPEUTICS, INC.   |  SOURCE GLOBAL, PBC   |  CLAROS TECHNOLOGIES, INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2026-04-17
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2026-04-03 
2022-11-29
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2022-11-15 
2021-12-22
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2021-12-08 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#